sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Healthcare / Gene Therapy

Gene Therapy Market By Type (Germ Line Gene Therapy and Somatic Gene Therapy), By Vector Type (Viral Vectors, Non-Viral Vectors, and Human Artificial Chromosome), and By Therapy Area (Cancer, Neurological Diseases, Infectious Diseases, Genetic Disorders, Rheumatoid Arthritis, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 – 2027

  • Publish On: Sep-2019
  • Total Pages: 185
  • Report Code: FAF-61
  • Base Year: 2018
  • Format:

Industry Insights

[185+ Pages PDF Report] Global gene therapy market was valued at approximately 1.4 billion in 2019 and is expected to reach a value of around USD 3.4 billion, at a CAGR of around 14.7% between 2019 and 2027.

The report covers the forecast and analysis of the gene therapy market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2027 based on revenue (USD Million). The study includes drivers and restraints of the gene therapy market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the gene therapy market on a global level.

In order to give the users of this report a comprehensive view of the gene therapy market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the gene therapy market by segmenting the market based on the type, vector type, therapy area, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2027. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Gene therapy is utilized for treating neurodegenerative disorders like Alzheimer's, amyotrophic lateral sclerosis, and spinal muscular atrophy. Gene therapy is one of the key treatment kinds that will propel the market growth over the forecast period. Moreover, gene therapy also finds lucrative applications in precision medicine. In addition to this, a rise in the occurrence of cancer is prompting the demand to treat the disease through gene therapy.

Based on the type, the market can be segregated into Germ Line Gene Therapy and Somatic Gene Therapy. In terms of vector type, the gene therapy industry can be divided into Viral Vectors, Non-Viral Vectors, and Human Artificial Chromosome. On the basis of the therapy area, the market for gene therapy can be classified into Cancer, Neurological Diseases, Infectious Diseases, Genetic Disorders, Rheumatoid Arthritis, and Others.

Global Gene Therapy : Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Key Features of Gene Therapy Report:

  • Gene Therapy structure: Overview, industry life cycle analysis, supply chain analysis
  • Gene Therapy : Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
  • Gene Therapy size, trend, and forecast analysis
  • Gene Therapy segments’ trend and forecast
  • Gene Therapy ’s competitive landscapes: Market share, Product portfolio, New product launches, etc.
  • Gene Therapy attractiveness and associated growth opportunities
  • Emerging trends in the Gene Therapy .
  • Strategic growth opportunities for the existing and new players
  • Key success factors

Benefits of Buying from Facts & Factors:

  • Our proven methodologies and systematic analysis help in making confident business and strategic decisions.
  • A market study that conducts at Facts & Factors Market Research can save significant cost and time, and can help prevent making costly mistakes.

Table of Content

  • Chapter 1. Executive Summary 23
  • Chapter 2. Gene Therapy market - Type Analysis 25
    • 2.1. Global Gene Therapy Market - Type Overview 25
    • 2.2. Global Gene Therapy Market Share, by Type, 2018 & 2025 (USD Million) 25
    • 2.3. Germ line Gene Therapy 27
      • 2.3.1. Global Germ line Gene Therapy Gene Therapy Market, 2016-2026 (USD Million) 27
    • 2.4. Somatic Gene Therapy 28
      • 2.4.1. Global Somatic Gene Therapy Gene Therapy Market, 2016-2026 (USD Million) 28
  • Chapter 3. Gene Therapy market - Vector Type Analysis 28
    • 3.1. Global Gene Therapy Market - Vector Type Overview 28
    • 3.2. Global Gene Therapy Market Share, by Vector Type, 2018 & 2025 (USD Million) 29
    • 3.3. Viral Vectors 30
      • 3.3.1. Global Viral Vectors Gene Therapy Market, 2016-2026 (USD Million) 30
    • 3.4. Non Viral Vectors 31
      • 3.4.1. Global Non Viral Vectors Gene Therapy Market, 2016-2026 (USD Million) 31
    • 3.5. Human Artificial Chromosome 32
      • 3.5.1. Global Human Artificial Chromosome Gene Therapy Market, 2016-2026 (USD Million) 32
  • Chapter 4. Gene Therapy market - Therapy Area Analysis 32
    • 4.1. Global Gene Therapy Market - Therapy Area Overview 32
    • 4.2. Global Gene Therapy Market Share, by Therapy Area, 2018 & 2025 (USD Million) 33
    • 4.3. Cancer 34
      • 4.3.1. Global Cancer Gene Therapy Market, 2016-2026 (USD Million) 34
    • 4.4. Infectious Diseases 35
      • 4.4.1. Global Infectious Diseases Gene Therapy Market, 2016-2026 (USD Million) 35
    • 4.5. Rheumatoid Arthritis 36
      • 4.5.1. Global Rheumatoid Arthritis Gene Therapy Market, 2016-2026 (USD Million) 36
    • 4.6. Genetic Disorders 37
      • 4.6.1. Global Genetic Disorders Gene Therapy Market, 2016-2026 (USD Million) 37
    • 4.7. Neurological Disorders 38
      • 4.7.1. Global Neurological Disorders Gene Therapy Market, 2016-2026 (USD Million) 38
    • 4.8. Others 39
      • 4.8.1. Global Others Gene Therapy Market, 2016-2026 (USD Million) 39
  • Chapter 5. Gene Therapy market - Regional Analysis 40
    • 5.1. Global Gene Therapy Market Regional Overview 40
    • 5.2. Global Gene Therapy Market Share, by Region, 2018 & 2025 (Value) 40
    • 5.3. North America 42
      • 5.3.1. North America Gene Therapy Market size and forecast, 2016-2026 42
      • 5.3.2. North America Gene Therapy Market, by Country, 2018 & 2025 (USD Million) 42
      • 5.3.3. North America Gene Therapy Market, by Type, 2016-2026 44
        • 5.3.3.1. North America Gene Therapy Market, by Type, 2016-2026 (USD Million) 44
      • 5.3.4. North America Gene Therapy Market, by Vector Type, 2016-2026 45
        • 5.3.4.1. North America Gene Therapy Market, by Vector Type, 2016-2026 (USD Million) 45
      • 5.3.5. North America Gene Therapy Market, by Therapy Area, 2016-2026 46
        • 5.3.5.1. North America Gene Therapy Market, by Therapy Area, 2016-2026 (USD Million) 46
      • 5.3.6. U.S. 47
        • 5.3.6.1. U.S. Market size and forecast, 2016-2026 (USD Million) 47
      • 5.3.7. Canada 48
        • 5.3.7.1. Canada Market size and forecast, 2016-2026 (USD Million) 48
      • 5.3.8. Mexico 49
        • 5.3.8.1. Mexico Market size and forecast, 2016-2026 (USD Million) 49
    • 5.4. Europe 50
      • 5.4.1. Europe Gene Therapy Market size and forecast, 2016-2026 50
      • 5.4.2. Europe Gene Therapy Market, by Country, 2018 & 2025 (USD Million) 50
      • 5.4.3. Europe Gene Therapy Market, by Type, 2016-2026 52
        • 5.4.3.1. Europe Gene Therapy Market, by Type, 2016-2026 (USD Million) 52
      • 5.4.4. Europe Gene Therapy Market, by Vector Type, 2016-2026 53
        • 5.4.4.1. Europe Gene Therapy Market, by Vector Type, 2016-2026 (USD Million) 53
      • 5.4.5. Europe Gene Therapy Market, by Therapy Area, 2016-2026 54
        • 5.4.5.1. Europe Gene Therapy Market, by Therapy Area, 2016-2026 (USD Million) 54
      • 5.4.6. Germany 55
        • 5.4.6.1. Germany Market size and forecast, 2016-2026 (USD Million) 55
      • 5.4.7. France 56
        • 5.4.7.1. France Market size and forecast, 2016-2026 (USD Million) 56
      • 5.4.8. U.K. 57
        • 5.4.8.1. U.K. Market size and forecast, 2016-2026 (USD Million) 57
      • 5.4.9. Italy 58
        • 5.4.9.1. Italy Market size and forecast, 2016-2026 (USD Million) 58
      • 5.4.10. Spain 59
        • 5.4.10.1. Spain Market size and forecast, 2016-2026 (USD Million) 59
      • 5.4.11. Nordic Countries 60
        • 5.4.11.1. Nordic Countries Market size and forecast, 2016-2026 (USD Million) 60
      • 5.4.12. Benelux Union 61
        • 5.4.12.1. Benelux Union Market size and forecast, 2016-2026 (USD Million) 61
      • 5.4.13. Rest of Europe 62
        • 5.4.13.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million) 62
    • 5.5. Asia Pacific 63
      • 5.5.1. Asia Pacific Gene Therapy Market size and forecast, 2016-2026 63
      • 5.5.2. Asia Pacific Gene Therapy Market, by Country, 2018 & 2025 (USD Million) 63
      • 5.5.3. Asia Pacific Gene Therapy Market, by Type, 2016-2026 65
        • 5.5.3.1. Asia Pacific Gene Therapy Market, by Type, 2016-2026 (USD Million) 65
      • 5.5.4. Asia Pacific Gene Therapy Market, by Vector Type, 2016-2026 66
        • 5.5.4.1. Asia Pacific Gene Therapy Market, by Vector Type, 2016-2026 (USD Million) 66
      • 5.5.5. Asia Pacific Gene Therapy Market, by Therapy Area, 2016-2026 67
        • 5.5.5.1. Asia Pacific Gene Therapy Market, by Therapy Area, 2016-2026 (USD Million) 67
      • 5.5.6. China 68
        • 5.5.6.1. China Market size and forecast, 2016-2026 (USD Million) 68
      • 5.5.7. Japan 69
        • 5.5.7.1. Japan Market size and forecast, 2016-2026 (USD Million) 69
      • 5.5.8. India 70
        • 5.5.8.1. India Market size and forecast, 2016-2026 (USD Million) 70
      • 5.5.9. New Zealand 71
        • 5.5.9.1. New Zealand Market size and forecast, 2016-2026 (USD Million) 71
      • 5.5.10. Australia 72
        • 5.5.10.1. Australia Market size and forecast, 2016-2026 (USD Million) 72
      • 5.5.11. South Korea 73
        • 5.5.11.1. South Korea Market size and forecast, 2016-2026 (USD Million) 73
      • 5.5.12. South-East Asia 74
        • 5.5.12.1. South-East Asia Market size and forecast, 2016-2026 (USD Million) 74
      • 5.5.13. Rest of Asia Pacific 75
        • 5.5.13.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million) 75
    • 5.6. Latin America 76
      • 5.6.1. Latin America Gene Therapy Market size and forecast, 2016-2026 76
      • 5.6.2. Latin America Gene Therapy Market, by Country, 2018 & 2025 (USD Million) 76
      • 5.6.3. Latin America Gene Therapy Market, by Type, 2016-2026 78
        • 5.6.3.1. Latin America Gene Therapy Market, by Type, 2016-2026 (USD Million) 78
      • 5.6.4. Latin America Gene Therapy Market, by Vector Type, 2016-2026 79
        • 5.6.4.1. Latin America Gene Therapy Market, by Vector Type, 2016-2026 (USD Million) 79
      • 5.6.5. Latin America Gene Therapy Market, by Therapy Area, 2016-2026 80
        • 5.6.5.1. Latin America Gene Therapy Market, by Therapy Area, 2016-2026 (USD Million) 80
      • 5.6.6. Brazil 81
        • 5.6.6.1. Brazil Market size and forecast, 2016-2026 (USD Million) 81
      • 5.6.7. Argentina 82
        • 5.6.7.1. Argentina Market size and forecast, 2016-2026 (USD Million) 82
      • 5.6.8. Rest of Latin America 83
        • 5.6.8.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Million) 83
    • 5.7. The Middle-East and Africa 84
      • 5.7.1. The Middle-East and Africa Gene Therapy Market size and forecast, 2016-2026 84
      • 5.7.2. The Middle-East and Africa Gene Therapy Market, by Country, 2018 & 2025 (USD Million) 84
      • 5.7.3. The Middle-East and Africa Gene Therapy Market, by Type, 2016-2026 86
        • 5.7.3.1. The Middle-East and Africa Gene Therapy Market, by Type, 2016-2026 (USD Million) 86
      • 5.7.4. The Middle-East and Africa Gene Therapy Market, by Vector Type, 2016-2026 87
        • 5.7.4.1. The Middle-East and Africa Gene Therapy Market, by Vector Type, 2016-2026 (USD Million) 87
      • 5.7.5. The Middle-East and Africa Gene Therapy Market, by Therapy Area, 2016-2026 88
        • 5.7.5.1. The Middle-East and Africa Gene Therapy Market, by Therapy Area, 2016-2026 (USD Million) 88
      • 5.7.6. Saudi Arabia 89
        • 5.7.6.1. Saudi Arabia Market size and forecast, 2016-2026 (USD Million) 89
      • 5.7.7. UAE 90
        • 5.7.7.1. UAE Market size and forecast, 2016-2026 (USD Million) 90
      • 5.7.8. Egypt 91
        • 5.7.8.1. Egypt Market size and forecast, 2016-2026 (USD Million) 91
      • 5.7.9. Kuwait 92
        • 5.7.9.1. Kuwait Market size and forecast, 2016-2026 (USD Million) 92
      • 5.7.10. South Africa 93
        • 5.7.10.1. South Africa Market size and forecast, 2016-2026 (USD Million) 93
      • 5.7.11. Rest of Middle-East Africa 94
        • 5.7.11.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million) 94
  • Chapter 6. Gene Therapy market - Competitive Landscape 95
    • 6.1. Competitor Market Share - Revenue 95
    • 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players 97
    • 6.3. Strategic Development 98
      • 6.3.1. Acquisitions and Mergers 98
      • 6.3.2. New Products 98
      • 6.3.3. Research & Development Activities 98
  • Chapter 7. Company Profiles 99
    • 7.1. Voyager Therapeutics, Inc. 99
      • 7.1.1. Company Overview 99
      • 7.1.2. Voyager Therapeutics, Inc. Revenue and Gross Margin 99
      • 7.1.3. Product portfolio 100
      • 7.1.4. Recent initiatives 101
    • 7.2. Spark Therapeutics, Inc. 101
      • 7.2.1. Company Overview 101
      • 7.2.2. Spark Therapeutics, Inc. Revenue and Gross Margin 101
      • 7.2.3. Product portfolio 102
      • 7.2.4. Recent initiatives 103
    • 7.3. Sangamo Therapeutics 103
      • 7.3.1. Company Overview 103
      • 7.3.2. Sangamo Therapeutics Revenue and Gross Margin 103
      • 7.3.3. Product portfolio 104
      • 7.3.4. Recent initiatives 105
    • 7.4. Human Stem Cells Institute PJSC 105
      • 7.4.1. Company Overview 105
      • 7.4.2. Human Stem Cells Institute PJSC Revenue and Gross Margin 105
      • 7.4.3. Product portfolio 106
      • 7.4.4. Recent initiatives 107
    • 7.5. Orchard Therapeutics plc 107
      • 7.5.1. Company Overview 107
      • 7.5.2. Orchard Therapeutics plc Revenue and Gross Margin 107
      • 7.5.3. Product portfolio 108
      • 7.5.4. Recent initiatives 109
    • 7.6. Genenta Science 109
      • 7.6.1. Company Overview 109
      • 7.6.2. Genenta Science Revenue and Gross Margin 109
      • 7.6.3. Product portfolio 110
      • 7.6.4. Recent initiatives 111
    • 7.7. Chiesi Farmaceutici S.p.A. 111
      • 7.7.1. Company Overview 111
      • 7.7.2. Chiesi Farmaceutici S.p.A. Revenue and Gross Margin 111
      • 7.7.3. Product portfolio 112
      • 7.7.4. Recent initiatives 113
    • 7.8. Novartis AG 113
      • 7.8.1. Company Overview 113
      • 7.8.2. Novartis AG Revenue and Gross Margin 113
      • 7.8.3. Product portfolio 114
      • 7.8.4. Recent initiatives 115
    • 7.9. GlaxoSmithKline PLC 115
      • 7.9.1. Company Overview 115
      • 7.9.2. GlaxoSmithKline PLC Revenue and Gross Margin 115
      • 7.9.3. Product portfolio 116
      • 7.9.4. Recent initiatives 117
    • 7.10. Gilead Sciences, Inc. 117
      • 7.10.1. Company Overview 117
      • 7.10.2. Gilead Sciences, Inc. Revenue and Gross Margin 117
      • 7.10.3. Product portfolio 118
      • 7.10.4. Recent initiatives 119
    • 7.11. Bristol - Myers Squibb Delta Company Limited 119
      • 7.11.1. Company Overview 119
      • 7.11.2. Bristol - Myers Squibb Delta Company Limited Revenue and Gross Margin 119
      • 7.11.3. Product portfolio 120
      • 7.11.4. Recent initiatives 121
    • 7.12. Advanced Cell & Gene Therapy, LLC 121
      • 7.12.1. Company Overview 121
      • 7.12.2. Advanced Cell & Gene Therapy, LLC Revenue and Gross Margin 121
      • 7.12.3. Product portfolio 122
      • 7.12.4. Recent initiatives 123
    • 7.13. Applied Genetic Technologies Corporation (AGTC) 123
      • 7.13.1. Company Overview 123
      • 7.13.2. Applied Genetic Technologies Corporation (AGTC) Revenue and Gross Margin 123
      • 7.13.3. Product portfolio 124
      • 7.13.4. Recent initiatives 125
    • 7.14. Audentes Therapeutics, Inc. 125
      • 7.14.1. Company Overview 125
      • 7.14.2. Audentes Therapeutics, Inc. Revenue and Gross Margin 125
      • 7.14.3. Product portfolio 126
      • 7.14.4. Recent initiatives 127
    • 7.15. Benitec Biopharma 127
      • 7.15.1. Company Overview 127
      • 7.15.2. Benitec Biopharma Revenue and Gross Margin 127
      • 7.15.3. Product portfolio 128
      • 7.15.4. Recent initiatives 129
    • 7.16. Biogen 129
      • 7.16.1. Company Overview 129
      • 7.16.2. Biogen Revenue and Gross Margin 129
      • 7.16.3. Product portfolio 130
      • 7.16.4. Recent initiatives 131
    • 7.17. Bluebird bio, Inc. 131
      • 7.17.1. Company Overview 131
      • 7.17.2. Bluebird bio, Inc. Revenue and Gross Margin 131
      • 7.17.3. Product portfolio 132
      • 7.17.4. Recent initiatives 133
    • 7.18. Genzyme Corporation 133
      • 7.18.1. Company Overview 133
      • 7.18.2. Genzyme Corporation Revenue and Gross Margin 133
      • 7.18.3. Product portfolio 134
      • 7.18.4. Recent initiatives 135
    • 7.19. Eurofins Genomics 135
      • 7.19.1. Company Overview 135
      • 7.19.2. Eurofins Genomics Revenue and Gross Margin 135
      • 7.19.3. Product portfolio 136
      • 7.19.4. Recent initiatives 137
    • 7.20. Pfizer Inc. 137
      • 7.20.1. Company Overview 137
      • 7.20.2. Pfizer Inc. Revenue and Gross Margin 137
      • 7.20.3. Product portfolio 138
      • 7.20.4. Recent initiatives 139
  • Chapter 8. Gene Therapy - Industry Analysis 140
    • 8.1. Gene Therapy Market - Key Trends 140
      • 8.1.1. Market Drivers 141
      • 8.1.2. Market Restraints 141
      • 8.1.3. Market Opportunities 142
    • 8.2. Value Chain Analysis 143
    • 8.3. Technology Roadmap and Timeline 144
    • 8.4. Gene Therapy Market - Attractiveness Analysis 145
      • 8.4.1. By Type 145
      • 8.4.2. By Vector Type 145
      • 8.4.3. By Therapy Area 146
      • 8.4.4. By Region 148
  • Chapter 9. Marketing Strategy Analysis, Distributors 149
    • 9.1. Marketing Channel 149
    • 9.2. Direct Marketing 150
    • 9.3. Indirect Marketing 150
    • 9.4. Marketing Channel Development Trend 150
    • 9.5. Economic/Political Environmental Change 151
  • Chapter 10. Report Conclusion 152
  • Chapter 11. Research Approach & Methodology 153
    • 11.1. Report Description 153
    • 11.2. Research Scope 154
    • 11.3. Research Methodology 154
      • 11.3.1. Secondary Research 155
      • 11.3.2. Primary Research 156
      • 11.3.3. Models 157
        • 11.3.3.1. Company Share Analysis Model 157
        • 11.3.3.2. Revenue Based Modeling 158
        • 11.3.3.3. Research Limitations 158

List of Figures

FIG. 1 Global Gene Therapy Market, 2016-2026 (USD Million) 24
FIG. 2 Global Gene Therapy Market Share, by Type, 2018 & 2025 (USD Million) 25
FIG. 3 Global Germ line Gene Therapy Gene Therapy Market, 2016-2026 (USD Million) 27
FIG. 4 Global Somatic Gene Therapy Gene Therapy Market, 2016-2026 (USD Million) 28
FIG. 5 Global Gene Therapy Market Share, by Vector Type, 2018 & 2025 (USD Million) 29
FIG. 6 Global Viral Vectors Gene Therapy Market, 2016-2026 (USD Million) 30
FIG. 7 Global Non Viral Vectors Gene Therapy Market, 2016-2026 (USD Million) 31
FIG. 8 Global Human Artificial Chromosome Gene Therapy Market, 2016-2026 (USD Million) 32
FIG. 9 Global Gene Therapy Market Share, by Therapy Area, 2018 & 2025 (USD Million) 33
FIG. 10 Global Cancer Gene Therapy Market, 2016-2026 (USD Million) 34
FIG. 11 Global Infectious Diseases Gene Therapy Market, 2016-2026 (USD Million) 35
FIG. 12 Global Rheumatoid Arthritis Gene Therapy Market, 2016-2026 (USD Million) 36
FIG. 13 Global Genetic Disorders Gene Therapy Market, 2016-2026 (USD Million) 37
FIG. 14 Global Neurological Disorders Gene Therapy Market, 2016-2026 (USD Million) 38
FIG. 15 Global Others Gene Therapy Market, 2016-2026 (USD Million) 39
FIG. 16 Global Gene Therapy Market Share, by Region, 2018 & 2025 40
FIG. 17 North America Gene Therapy Market, 2016-2026 42
FIG. 18 U.S. Gene Therapy Market, 2016-2026 47
FIG. 19 Canada Gene Therapy Market, 2016-2026 48
FIG. 20 Mexico Gene Therapy Market, 2016-2026 49
FIG. 21 Europe Gene Therapy Market, 2016-2026 50
FIG. 22 Germany Gene Therapy Market, 2016-2026 55
FIG. 23 France Gene Therapy Market, 2016-2026 56
FIG. 24 U.K. Gene Therapy Market, 2016-2026 57
FIG. 25 Italy Gene Therapy Market, 2016-2026 58
FIG. 26 Spain Gene Therapy Market, 2016-2026 59
FIG. 27 Nordic Countries Gene Therapy Market, 2016-2026 60
FIG. 28 Benelux Union Gene Therapy Market, 2016-2026 61
FIG. 29 Rest of Europe Gene Therapy Market, 2016-2026 62
FIG. 30 Asia Pacific Gene Therapy Market, 2016-2026 63
FIG. 31 China Gene Therapy Market, 2016-2026 68
FIG. 32 Japan Gene Therapy Market, 2016-2026 69
FIG. 33 India Gene Therapy Market, 2016-2026 70
FIG. 34 New Zealand Gene Therapy Market, 2016-2026 71
FIG. 35 Australia Gene Therapy Market, 2016-2026 72
FIG. 36 South  Korea Gene Therapy Market, 2016-2026 73
FIG. 37 South-East Asia Gene Therapy Market, 2016-2026 74
FIG. 38 Rest of Asia Pacific Gene Therapy Market, 2016-2026 75
FIG. 39 Latin America Gene Therapy Market, 2016-2026 76
FIG. 40 Brazil Gene Therapy Market, 2016-2026 81
FIG. 41 Argentina Gene Therapy Market, 2016-2026 82
FIG. 42 Rest of Latin America Gene Therapy Market, 2016-2026 83
FIG. 43 The Middle-East and Africa Gene Therapy Market, 2016-2026 84
FIG. 44 Saudi Arabia Gene Therapy Market, 2016-2026 89
FIG. 45 UAE Gene Therapy Market, 2016-2026 90
FIG. 46 Egypt Gene Therapy Market, 2016-2026 91
FIG. 47 Kuwait Gene Therapy Market, 2016-2026 92
FIG. 48 South Africa Gene Therapy Market, 2016-2026 93
FIG. 49 Rest of Middle-East Africa Gene Therapy Market, 2016-2026 94
FIG. 50 Competitor Market Share – Revenue 95
FIG. 51 Voyager Therapeutics, Inc. Revenue and Growth Rate 100
FIG. 52 Voyager Therapeutics, Inc. Market Share 100
FIG. 53 Spark Therapeutics, Inc. Revenue and Growth Rate 102
FIG. 54 Spark Therapeutics, Inc. Market Share 102
FIG. 55 Sangamo Therapeutics Revenue and Growth Rate 104
FIG. 56 Sangamo Therapeutics Market Share 104
FIG. 57 Human Stem Cells Institute PJSC Revenue and Growth Rate 106
FIG. 58 Human Stem Cells Institute PJSC Market Share 106
FIG. 59 Orchard Therapeutics plc Revenue and Growth Rate 108
FIG. 60 Orchard Therapeutics plc Market Share 108
FIG. 61 Genenta Science Revenue and Growth Rate 110
FIG. 62 Genenta Science Market Share 110
FIG. 63 Chiesi Farmaceutici S.p.A. Revenue and Growth Rate 112
FIG. 64 Chiesi Farmaceutici S.p.A. Market Share 112
FIG. 65 Novartis AG Revenue and Growth Rate 114
FIG. 66 Novartis AG Market Share 114
FIG. 67 GlaxoSmithKline PLC Revenue and Growth Rate 116
FIG. 68 GlaxoSmithKline PLC Market Share 116
FIG. 69 Gilead Sciences, Inc. Revenue and Growth Rate 118
FIG. 70 Gilead Sciences, Inc. Market Share 118
FIG. 71 Bristol - Myers Squibb Delta Company Limited Revenue and Growth Rate 120
FIG. 72 Bristol - Myers Squibb Delta Company Limited Market Share 120
FIG. 73 Advanced Cell & Gene Therapy, LLC Revenue and Growth Rate 122
FIG. 74 Advanced Cell & Gene Therapy, LLC Market Share 122
FIG. 75 Applied Genetic Technologies Corporation (AGTC) Revenue and Growth Rate 124
FIG. 76 Applied Genetic Technologies Corporation (AGTC) Market Share 124
FIG. 77 Audentes Therapeutics, Inc. Revenue and Growth Rate 126
FIG. 78 Audentes Therapeutics, Inc. Market Share 126
FIG. 79 Benitec Biopharma Revenue and Growth Rate 128
FIG. 80 Benitec Biopharma Market Share 128
FIG. 81 Biogen Revenue and Growth Rate 130
FIG. 82 Biogen Market Share 130
FIG. 83 Bluebird bio, Inc. Revenue and Growth Rate 132
FIG. 84 Bluebird bio, Inc. Market Share 132
FIG. 85 Genzyme Corporation Revenue and Growth Rate 134
FIG. 86 Genzyme Corporation Market Share 134
FIG. 87 Eurofins Genomics Revenue and Growth Rate 136
FIG. 88 Eurofins Genomics Market Share 136
FIG. 89 Pfizer Inc. Revenue and Growth Rate 138
FIG. 90 Pfizer Inc. Market Share 138
FIG. 91 Market Dynamics 140
FIG. 92 Global Gene Therapy – Value Chain Analysis 143
FIG. 93 Technology Roadmap and Timeline 144
FIG. 94 Market Attractiveness Analysis – By Type 145
FIG. 95 Market Attractiveness Analysis – By Vector Type 146
FIG. 96 Market Attractiveness Analysis – By Therapy Area 146
FIG. 97 Market Attractiveness Analysis – By Region 148
FIG. 98 Market Channel 149
FIG. 99 Marketing Channel Development Trend 150
FIG. 100 Growth in World Gross Product, 2008-2018 151
 


List of Tables

TABLE 1 Global Gene Therapy Market, 2018 & 2025 (USD Million) 23
TABLE 2 Global Gene Therapy market, by Type, 2016-2026 (USD Million) 25
TABLE 3 Global Gene Therapy market, by Vector Type, 2016-2026 (USD Million) 29
TABLE 4 Global Gene Therapy market, by Therapy Area, 2016-2026 (USD Million) 33
TABLE 5 Global Gene Therapy market, by Region, 2016-2026 (USD Million) 40
TABLE 6 North America Gene Therapy Market, by Type, 2016-2026 (USD Million) 44
TABLE 7 North America Gene Therapy Market, by Vector Type, 2016-2026 (USD Million) 45
TABLE 8 North America Gene Therapy Market, by Therapy Area, 2016-2026 (USD Million) 46
TABLE 9 Europe Gene Therapy Market, by Type, 2016-2026 (USD Million) 52
TABLE 10 Europe Gene Therapy Market, by Vector Type, 2016-2026 (USD Million) 53
TABLE 11 Europe Gene Therapy Market, by Therapy Area, 2016-2026 (USD Million) 54
TABLE 12 Asia Pacific Gene Therapy Market, by Type, 2016-2026 (USD Million) 65
TABLE 13 Asia Pacific Gene Therapy Market, by Vector Type, 2016-2026 (USD Million) 66
TABLE 14 Asia Pacific Gene Therapy Market, by Therapy Area, 2016-2026 (USD Million) 67
TABLE 15 Latin America Gene Therapy Market, by Type, 2016-2026 (USD Million) 78
TABLE 16 Latin America Gene Therapy Market, by Vector Type, 2016-2026 (USD Million) 79
TABLE 17 Latin America Gene Therapy Market, by Therapy Area, 2016-2026 (USD Million) 80
TABLE 18 The Middle-East and Africa Gene Therapy Market, by Type, 2016-2026 (USD Million) 86
TABLE 19 The Middle-East and Africa Gene Therapy Market, by Vector Type, 2016-2026 (USD Million) 87
TABLE 20 The Middle-East and Africa Gene Therapy Market, by Therapy Area, 2016-2026 (USD Million) 88
TABLE 21 Global Gene Therapy Market - Company Revenue Analysis 2016-2018 (USD Million) 95
TABLE 22 Global Gene Therapy Market - Company Revenue Share Analysis 2016-2018 (%) 97
TABLE 23 Acquisitions and Mergers 98
TABLE 24 New Product/Service Launch 98
TABLE 25 Research & Development Activities 98
TABLE 26 Market Drivers 141
TABLE 27 Market Restraints 141
TABLE 28 Market Opportunities 142
 

Industry Major Market Players

  • Advanced Cell & Gene Therapy,
  • Audentes Therapeutics,
  • Benitec Biopharma,
  • Biogen,
  • Blubird Bio Inc.,
  • Bristol-Myers Squibb Company,
  • CHIESI Farmaceutici SPA,
  • Eurofins Scientific,
  • Geneta Science,
  • Genzyme Corporation,
  • Gilead,
  • GlaxoSmithKline PLC
     

Related Reports

3D Optical Microscope Market By Industry Type (Aerospace & Automotive, Healthcare, Manufacturing and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

[185+ Pages PDF Report]Global optical microscope market was valued at USD 170 million in 2019, and is predicted to reach around USD 280 million by 2026, and is expected to predict the 3D optical microscope market growth in terms of CAGR of 8% during the forecast year. This specializedandexpertis...Read More

Nov-2020 | Price : $ 3850.00 | Pages: 185 | Report Code: ZMR-1343 | Report Format:

Cone Beam Computed Tomography (CBCT) Market By Application (Dental Applications, Implantology, Oral and Maxillofacial Surgery, Orthodontics, Endodontics, General Dentistry, Temporomandibular Joint (TMJ) Disorders, Periodontics, Forensic Dentistry and Other Applications) By patient Position (Standing/Seated, Seated and Supine) For Hospitals, Clinics and Research Institutes: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026

This specializedexpertise oriented industry research report scrutinizes the technical and commercial business outlook of the Cone beam computed tomography (CBCT) industry. The report analyzes and declares the historical and current trends analysis of the Cone beam computed tomography (CBCT) indust...Read More

Sep-2020 | Price : $ 3850.00 | Pages: 190 | Report Code: ZMR-1311 | Report Format:

Plasma Therapy Market Type (Pure PRP, Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), Source (Autologous, Allogenic), Application (Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, Others), End User (Hospitals & Clinics, Research Institutions): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Plasma Therapy industry. The report analyzes and declares the historical and current trends analysis of the Plasma Therapy industry and subsequently recommends the proj...Read More

Sep-2020 | Price : $ 3850.00 | Pages: 130 | Report Code: ZMR-1279 | Report Format:

Pneumonia Therapeutics Market by Product Type (Drugs (Branded and Generics), Vaccines, and Oxygen Therapy), and Regions: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

This specializedandexpertise oriented industry research report scrutinizes the technical and commercial business outlook of the pneumonia therapeutics industry. The report analyzes and declares the historical and current trends analysis of the pneumonia therapeutics industry and subsequently recom...Read More

Sep-2020 | Price : $ 3850.00 | Pages: 190 | Report Code: ZMR-1271 | Report Format:

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions